X
Staff Correspondent

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

  • Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
  • Net sales decreased 41% to $58.3 million
  • Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

Categories: AlphaGraphs Earnings Health Care
Tags: Medical Devices
Related Post
  1. Earnings Summary: Trimble reports Q1 2024 financial results

    Trimble Inc. (NASDAQ: TRMB), a provider of navigation systems and data collection systems, on Friday…

  2. Earnings Summary: Highlights of Cboe Global Markets’ (CBOE) Q1 2024 results

    Financial services company Cboe Global Markets, Inc. (Cboe: CBOE) on Friday announced an increase in…

  3. Earnings Summary: Molson Coors reports higher sales and profit for Q1 2024

    Molson Coors Beverage Company (NYSE: TAP) has announced first-quarter 2024 financial results, reporting an increase…

PRODUCTS

ABOUT US

GROUPS